|
OIP5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.489800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.856200E-01 |
| Normal-vs-Stage2 |
1.042610E-01 |
| Normal-vs-Stage3 |
6.459000E-01 |
| Normal-vs-Stage4 |
7.100400E-01 |
| Stage1-vs-Stage2 |
2.827500E-04 |
| Stage1-vs-Stage3 |
2.744200E-01 |
| Stage1-vs-Stage4 |
4.752800E-01 |
| Stage2-vs-Stage3 |
1.383520E-02 |
| Stage2-vs-Stage4 |
4.366000E-02 |
| Stage3-vs-Stage4 |
9.167600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.660400E-01 |
| Normal-vs-AfricanAmerican |
1.773990E-01 |
| Normal-vs-Asian |
6.106800E-01 |
| Caucasian-vs-AfricanAmerican |
1.315810E-02 |
| Caucasian-vs-Asian |
2.480600E-01 |
| AfricanAmerican-vs-Asian |
1.721800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.472400E-01 |
| Normal-vs-Female |
7.544200E-01 |
| Male-vs-Female |
9.704000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.973600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.322400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.329200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.548000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.816600E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.171200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.381600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.444400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.578400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.467600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.983000E-01 |
| Classical-VS-Follicular |
7.799800E-02 |
| Classical-VS-Other |
4.643200E-01 |
| Classical-VS-Normal |
8.218400E-01 |
| Tall-VS-Follicular |
4.038100E-02 |
| Tall-VS-Other |
7.409600E-01 |
| Tall-VS-Normal |
6.907800E-01 |
| Follicular-VS-Other |
1.186800E-01 |
| Follicular-VS-Normal |
3.410800E-01 |
| Other-VS-Normal |
5.498000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.703200E-01 |
| Normal-vs-N1 |
6.865200E-01 |
| N0-vs-N1 |
9.945200E-01 |
|
|
